Option chain shows key data for Eloxx Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Eloxx Pharmaceuticals.

Eloxx Pharmaceuticals (OTC:ELOX) Stock, Option Chain

Eloxx Pharmaceuticals

Eloxx Pharmaceuticals Inc is a clinical-stage biopharmaceutical company engaged in the science of ribosome modulation, leveraging both its ZM chemistry technology platform and its library of novel aminoglycosides to develop novel oral small molecule Ribosome Modulating Agents (RMAs) and Eukaryotic Ribosome Selective Glycosides (ERSGs), for the treatment of rare and ultra-rare genetic diseases where patients have point nonsense genetic mutations that result in premature stop codons and less than full-length proteins. The ELX-02, the company's investigational drug product candidate, is a small molecule designed to restore the production of full-length functional proteins.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

AGBA

AGIL

AIXI

AURC

BEDU

BLIN

BLTE

BSAQ

BTAI

CLAR

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CURO

CWCO

EBIX

ELOX

ERAS

ESGL

FATH

FTRE

FWAC

HRYU

JTAI

LICY

LWAY

Airspan Networks Holdings Inc. Common Stock

MIMO

NAAS

NKLA

ORGN

ORIC

RVLP

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SDPI

SMMT

SNCE

SOUN

SVFD

TDUP

TSHA

VALN

VCIG

VEDU

XXII

YELL

ZYNE

Gainers


	Zynerba Pharmaceuticals, Inc.  (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration of up to $200 million in cash.


Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pre-Market Outlook

AMRS

LIFW

MOGO

MYNZ

PTRA

Gainers


	AGBA Group Holding Limited  (NASDAQ: AGBA) shares surged 49.4% to $1.31 in pre-market trading after the company reported a 325% year-over-year growth in its second-quarter revenue.


Why US Steel Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket

AULT

CAMT

CVKD

CVNA

CYRX

EDTX

FWBI

GBIO

GLMD

HCTI

HIVE

Hycroft Mining Holding Corporation - Class A Common Stock

HYMC

HYZN

JFIN

JZXN

LGHL

MBRX

MLKN

NFTG

PPSI

RKLB

SIFY

SNAL

SNPX

SSYS

SURG

SXTP

TGTX

TTOO

VINE

VSAT

WULF

Why Progressive Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Thursday&#39;s Mid-Day Session

ELOXX PHARMACEUTICALS INC by Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals Inc

Press Releases

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to License ZKN-013 for Rare Dermatological Diseases

Health Care

General

Almirall and Eloxx Pharmaceuticals Enter into Exclusive Agreement to license ZKN-013 for rare dermatological diseases

Comments

Eloxx Pharmaceuticals

Eloxx Pharmaceuticals (ELOX) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga